Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Patient education for children with interstitial lung diseases and their caregivers: A pilot study.

Niemitz M, Schrader M, Carlens J, Hengst M, Eismann C, Goldbeck L, Griese M, Schwerk N.

Patient Educ Couns. 2019 Jan 23. pii: S0738-3991(19)30028-X. doi: 10.1016/j.pec.2019.01.016. [Epub ahead of print]

PMID:
30709570
2.

Early onset children's interstitial lung diseases: Discrete entities or manifestations of pulmonary dysmaturity?

Bush A, Griese M, Seidl E, Kerem E, Reu S, Nicholson AG.

Paediatr Respir Rev. 2018 Oct 9. pii: S1526-0542(18)30133-7. doi: 10.1016/j.prrv.2018.09.004. [Epub ahead of print] Review.

PMID:
30552058
3.

Congenital Vertical Tracheal Septum Misdiagnosed as Laryngomalacia.

Reiter K, Kramer J, Griese M, Kammer B.

Am J Respir Crit Care Med. 2018 Nov 8. doi: 10.1164/rccm.201805-0891IM. [Epub ahead of print] No abstract available.

PMID:
30407842
4.

Bi-allelic Mutations in Phe-tRNA Synthetase Associated with a Multi-system Pulmonary Disease Support Non-translational Function.

Xu Z, Lo WS, Beck DB, Schuch LA, Oláhová M, Kopajtich R, Chong YE, Alston CL, Seidl E, Zhai L, Lau CF, Timchak D, LeDuc CA, Borczuk AC, Teich AF, Juusola J, Sofeso C, Müller C, Pierre G, Hilliard T, Turnpenny PD, Wagner M, Kappler M, Brasch F, Bouffard JP, Nangle LA, Yang XL, Zhang M, Taylor RW, Prokisch H, Griese M, Chung WK, Schimmel P.

Am J Hum Genet. 2018 Jul 5;103(1):100-114. doi: 10.1016/j.ajhg.2018.06.006.

5.

Pulmonary interstitial glycogenosis - A systematic analysis of new cases.

Seidl E, Carlens J, Reu S, Wetzke M, Ley-Zaporozhan J, Brasch F, Wesselak T, Schams A, Rauch D, Schuch L, Kappler M, Schelstraete P, Wolf M, Stehling F, Haarmann E, Borensztajn D, van de Loo M, Rubak S, Lex C, Hinrichs B, Reiter K, Schwerk N, Griese M.

Respir Med. 2018 Jul;140:11-20. doi: 10.1016/j.rmed.2018.05.009. Epub 2018 May 17. Review.

PMID:
29957271
6.

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Schäfer J, Griese M, Chandrasekaran R, Chotirmall SH, Hartl D.

BMC Pulm Med. 2018 May 22;18(1):79. doi: 10.1186/s12890-018-0630-8. Review.

7.

Development and validation of a health-related quality of life questionnaire for pediatric patients with interstitial lung disease.

Niemitz M, Schwerk N, Goldbeck L, Griese M.

Pediatr Pulmonol. 2018 Jul;53(7):954-963. doi: 10.1002/ppul.24018. Epub 2018 Apr 23.

PMID:
29687642
8.

Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood.

Hengst M, Naehrlich L, Mahavadi P, Grosse-Onnebrink J, Terheggen-Lagro S, Skanke LH, Schuch LA, Brasch F, Guenther A, Reu S, Ley-Zaporozhan J, Griese M.

Orphanet J Rare Dis. 2018 Mar 27;13(1):42. doi: 10.1186/s13023-018-0780-z.

9.

ABCA3 missense mutations causing surfactant dysfunction disorders have distinct cellular phenotypes.

Schindlbeck U, Wittmann T, Höppner S, Kinting S, Liebisch G, Hegermann J, Griese M.

Hum Mutat. 2018 Jun;39(6):841-850. doi: 10.1002/humu.23416. Epub 2018 Mar 25.

PMID:
29505158
10.

Chronic interstitial lung disease in children.

Griese M.

Eur Respir Rev. 2018 Feb 7;27(147). pii: 170100. doi: 10.1183/16000617.0100-2017. Print 2018 Mar 31. Review.

11.

Functional rescue of misfolding ABCA3 mutations by small molecular correctors.

Kinting S, Höppner S, Schindlbeck U, Forstner ME, Harfst J, Wittmann T, Griese M.

Hum Mol Genet. 2018 Mar 15;27(6):943-953. doi: 10.1093/hmg/ddy011.

PMID:
29325094
12.

An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis.

Stanke F, Hector A, Hedtfeld S, Hartl D, Griese M, Tümmler B, Mall MA.

Eur Respir J. 2017 Dec 28;50(6). pii: 1700426. doi: 10.1183/13993003.00426-2017. Print 2017 Dec. No abstract available.

PMID:
29284683
13.

Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and neonates.

Papan C, Meyer-Buehn M, Laniado G, Nicolai T, Griese M, Huebner J.

Infection. 2018 Apr;46(2):189-196. doi: 10.1007/s15010-017-1088-y. Epub 2017 Oct 31.

PMID:
29086343
14.

International management platform for children's interstitial lung disease (chILD-EU).

Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N, Emiralioğlu N, Snijders D, Goldbeck L, Leidl R, Ley-Zaporozhan J, Krüger-Stollfuss I, Kammer B, Wesselak T, Eismann C, Schams A, Neuner D, MacLean M, Nicholson AG, Lauren M, Clement A, Epaud R, de Blic J, Ashworth M, Aurora P, Calder A, Wetzke M, Kappler M, Cunningham S, Schwerk N, Bush A; the other chILD-EU collaborators.

Thorax. 2018 Mar;73(3):231-239. doi: 10.1136/thoraxjnl-2017-210519. Epub 2017 Oct 22.

15.

Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.

Donaldson SH, Pilewski JM, Griese M, Cooke J, Viswanathan L, Tullis E, Davies JC, Lekstrom-Himes JA, Wang LT; VX11-661-101 Study Group.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):214-224. doi: 10.1164/rccm.201704-0717OC.

16.

Quantification of volume and lipid filling of intracellular vesicles carrying the ABCA3 transporter.

Höppner S, Kinting S, Torrano AA, Schindlbeck U, Bräuchle C, Zarbock R, Wittmann T, Griese M.

Biochim Biophys Acta Mol Cell Res. 2017 Dec;1864(12):2330-2335. doi: 10.1016/j.bbamcr.2017.08.013. Epub 2017 Sep 6.

17.

Pulmonary Alveolar Proteinosis: A Comprehensive Clinical Perspective.

Griese M.

Pediatrics. 2017 Aug;140(2). pii: e20170610. doi: 10.1542/peds.2017-0610. Review.

18.

Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.

Bonella F, Long X, He X, Ohshimo S, Griese M, Guzman J, Costabel U.

Respirology. 2017 Oct;22(7):1371-1378. doi: 10.1111/resp.13082. Epub 2017 May 31.

19.

Increasing Total Serum IgE, Allergic Bronchopulmonary Aspergillosis, and Lung Function in Cystic Fibrosis.

Gothe F, Kappler M, Griese M.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1591-1598.e6. doi: 10.1016/j.jaip.2017.03.033. Epub 2017 May 16.

PMID:
28526275
20.

Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione.

Corti A, Griese M, Hector A, Pompella A.

J Cyst Fibros. 2017 May;16(3):342-345. doi: 10.1016/j.jcf.2016.12.002. Epub 2016 Dec 14.

PMID:
27988297
21.

Management of children with interstitial lung diseases: the difficult issue of acute exacerbations.

Clement A, de Blic J, Epaud R, Galeron L, Nathan N, Hadchouel A, Barbato A, Snijders D, Kiper N, Cunningham S, Griese M, Bush A, Schwerk N; chILD-EU collaboration.

Eur Respir J. 2016 Dec;48(6):1559-1563. doi: 10.1183/13993003.01900-2016. No abstract available.

22.

Pott's disease: a major issue for an unaccompanied refugee minor.

Papan C, von Both U, Kappler M, Kammer B, Griese M, Huebner J.

Thorax. 2017 Mar;72(3):282-283. doi: 10.1136/thoraxjnl-2016-209468. Epub 2016 Nov 21.

PMID:
27872320
23.

Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.

Long X, He X, Ohshimo S, Griese M, Sarria R, Guzman J, Costabel U, Bonella F.

Eur Respir J. 2017 Feb 23;49(2). pii: 1501924. doi: 10.1183/13993003.01924-2015. Print 2017 Feb.

24.

Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.

Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters J, Nakata K, Van Moorsel CH, Costabel U, Cottin V, Ichiwata T, Inoue Y, Braschi A, Bonizzoni G, Iotti GA, Tinelli C, Rodi G; WLL International Study Group.

Orphanet J Rare Dis. 2016 Aug 31;11(1):115. doi: 10.1186/s13023-016-0497-9.

25.

Delivery of Alpha-1 Antitrypsin to Airways.

Griese M, Scheuch G.

Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S346-51. doi: 10.1513/AnnalsATS.201507-469KV. Review.

PMID:
27564672
26.

Lung disease caused by ABCA3 mutations.

Kröner C, Wittmann T, Reu S, Teusch V, Klemme M, Rauch D, Hengst M, Kappler M, Cobanoglu N, Sismanlar T, Aslan AT, Campo I, Proesmans M, Schaible T, Terheggen-Lagro S, Regamey N, Eber E, Seidenberg J, Schwerk N, Aslanidis C, Lohse P, Brasch F, Zarbock R, Griese M.

Thorax. 2017 Mar;72(3):213-220. doi: 10.1136/thoraxjnl-2016-208649. Epub 2016 Aug 11.

PMID:
27516224
27.

TTC25 Deficiency Results in Defects of the Outer Dynein Arm Docking Machinery and Primary Ciliary Dyskinesia with Left-Right Body Asymmetry Randomization.

Wallmeier J, Shiratori H, Dougherty GW, Edelbusch C, Hjeij R, Loges NT, Menchen T, Olbrich H, Pennekamp P, Raidt J, Werner C, Minegishi K, Shinohara K, Asai Y, Takaoka K, Lee C, Griese M, Memari Y, Durbin R, Kolb-Kokocinski A, Sauer S, Wallingford JB, Hamada H, Omran H.

Am J Hum Genet. 2016 Aug 4;99(2):460-9. doi: 10.1016/j.ajhg.2016.06.014.

28.

A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis.

Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters JC, Nakata K, Van Moorsel CH, Costabel U, Cottin V, Ichiwata T, Inoue Y, Braschi A, Bonizzoni G, Iotti GA, Tinelli C, Rodi G; WLL International Study Group.

Chest. 2016 Jul;150(1):251-3. doi: 10.1016/j.chest.2016.04.030. No abstract available.

29.

Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.

Kappler M, Nagel F, Feilcke M, Kröner C, Pawlita I, Naehrig S, Ripper J, Hengst M, von Both U, Forstner M, Hector A, Griese M.

Pediatr Pulmonol. 2016 Oct;51(10):1010-1019. doi: 10.1002/ppul.23519. Epub 2016 Jul 5.

PMID:
27378061
30.

European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity.

Bush A, Barbato A, Clement A, Cunningham S, Blic Jd, Gilbert C, Goldbeck L, Kiper N, Schwerk N, Griese M.

Eur Respir J. 2016 Jul;48(1):282-3. doi: 10.1183/13993003.00505-2016. No abstract available.

31.

Homooligomerization of ABCA3 and its functional significance.

Frixel S, Lotz-Havla AS, Kern S, Kaltenborn E, Wittmann T, Gersting SW, Muntau AC, Zarbock R, Griese M.

Int J Mol Med. 2016 Aug;38(2):558-66. doi: 10.3892/ijmm.2016.2650. Epub 2016 Jun 21.

PMID:
27352740
32.

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Spathis A, Mazioti A, Tomos I, Papanikolaou I, Loukides S, Chainis K, Karakitsos P, Griese M, Papiris S.

PLoS One. 2016 Jun 23;11(6):e0157789. doi: 10.1371/journal.pone.0157789. eCollection 2016.

33.

Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency.

Fuchs SI, Schwerk N, Pittschieler K, Ahrens F, Baden W, Bals R, Fähndrich S, Gleiber W, Griese M, Hülskamp G, Köhnlein T, Reckling L, Rietschel E, Staab D, Gappa M.

Respir Med. 2016 Jul;116:93-9. doi: 10.1016/j.rmed.2016.04.015. Epub 2016 Apr 27.

34.

Tools to explore ABCA3 mutations causing interstitial lung disease.

Wittmann T, Schindlbeck U, Höppner S, Kinting S, Frixel S, Kröner C, Liebisch G, Hegermann J, Aslanidis C, Brasch F, Reu S, Lasch P, Zarbock R, Griese M.

Pediatr Pulmonol. 2016 Dec;51(12):1284-1294. doi: 10.1002/ppul.23471. Epub 2016 May 13.

PMID:
27177387
35.

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.

Bonella F, Long X, Ohshimo S, Horimasu Y, Griese M, Guzman J, Kohno N, Costabel U.

Orphanet J Rare Dis. 2016 Apr 23;11:48. doi: 10.1186/s13023-016-0430-2.

36.

Chitinase activation in patients with fungus-associated cystic fibrosis lung disease.

Hector A, Chotirmall SH, Lavelle GM, Mirković B, Horan D, Eichler L, Mezger M, Singh A, Ralhan A, Berenbrinker S, Mack I, Ensenauer R, Riethmüller J, Graepler-Mainka U, Murray MA, Griese M, McElvaney NG, Hartl D.

J Allergy Clin Immunol. 2016 Oct;138(4):1183-1189.e4. doi: 10.1016/j.jaci.2016.01.031. Epub 2016 Apr 4.

PMID:
27056270
37.

Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases.

Hofmann N, Galetskiy D, Rauch D, Wittmann T, Marquardt A, Griese M, Zarbock R.

PLoS One. 2016 Mar 31;11(3):e0152594. doi: 10.1371/journal.pone.0152594. eCollection 2016.

38.

Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3.

Wittmann T, Frixel S, Höppner S, Schindlbeck U, Schams A, Kappler M, Hegermann J, Wrede C, Liebisch G, Vierzig A, Zacharasiewicz A, Kopp MV, Poets CF, Baden W, Hartl D, van Kaam AH, Lohse P, Aslanidis C, Zarbock R, Griese M.

Mol Med. 2016 Sep;22:183-191. doi: 10.2119/molmed.2015.00244. Epub 2016 Feb 26.

39.

Microbial colonization and lung function in adolescents with cystic fibrosis.

Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D.

J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5.

40.

Pulmonary alveolar proteinosis in a cat.

Szatmári V, Teske E, Nikkels PG, Griese M, de Jong PA, Grinwis G, Theegarten D, Veraa S, van Steenbeek FG, Drent M, Bonella F.

BMC Vet Res. 2015 Dec 9;11:302. doi: 10.1186/s12917-015-0613-4.

41.

Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.

Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, Kerem E.

Pediatr Pulmonol. 2016 Feb;51(2):143-6. doi: 10.1002/ppul.23344. Epub 2015 Nov 19.

PMID:
26583331
42.

Cardiovascular risk in pulmonary alveolar proteinosis.

Manali ED, Papadaki G, Konstantonis D, Tsangaris I, Papaioannou AI, Kolilekas L, Schams A, Kagouridis K, Karakatsani A, Orfanos S, Griese M, Papiris SA.

Expert Rev Respir Med. 2016 Feb;10(2):235-40. doi: 10.1586/17476348.2016.1116389. Epub 2015 Nov 27.

PMID:
26558331
43.

Persistent Tachypnea of Infancy. Usual and Aberrant.

Rauch D, Wetzke M, Reu S, Wesselak W, Schams A, Hengst M, Kammer B, Ley-Zaporozhan J, Kappler M, Proesmans M, Lange J, Escribano A, Kerem E, Ahrens F, Brasch F, Schwerk N, Griese M; PTI (Persistent Tachypnea of Infancy) Study Group of the Kids Lung Register.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):438-47. doi: 10.1164/rccm.201508-1655OC.

44.

Pushing chILD Forward: The Bright Future of Children's Interstitial Lung Diseases.

Griese M.

Ann Am Thorac Soc. 2015 Oct;12(10):1428-9. doi: 10.1513/AnnalsATS.201508-550ED. No abstract available.

PMID:
26448346
45.

Categorizing diffuse parenchymal lung disease in children.

Griese M, Irnstetter A, Hengst M, Burmester H, Nagel F, Ripper J, Feilcke M, Pawlita I, Gothe F, Kappler M, Schams A, Wesselak T, Rauch D, Wittmann T, Lohse P, Brasch F, Kröner C.

Orphanet J Rare Dis. 2015 Sep 25;10:122. doi: 10.1186/s13023-015-0339-1.

46.

Surfactant proteins in pediatric interstitial lung disease.

Griese M, Lorenz E, Hengst M, Schams A, Wesselak T, Rauch D, Wittmann T, Kirchberger V, Escribano A, Schaible T, Baden W, Schulze J, Krude H, Aslanidis C, Schwerk N, Kappler M, Hartl D, Lohse P, Zarbock R.

Pediatr Res. 2016 Jan;79(1-1):34-41. doi: 10.1038/pr.2015.173. Epub 2015 Sep 16.

PMID:
26375475
47.

Respiratory Bronchiolitis-Associated Interstitial Lung Disease in Childhood: New Sequela of Smoking.

Sismanlar T, Aslan AT, Turktas H, Memis L, Griese M.

Pediatrics. 2015 Oct;136(4):e1026-9. doi: 10.1542/peds.2015-1303. Epub 2015 Sep 7.

48.

GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.

Griese M, Zarbock R, Costabel U, Hildebrandt J, Theegarten D, Albert M, Thiel A, Schams A, Lange J, Krenke K, Wesselak T, Schön C, Kappler M, Blum H, Krebs S, Jung A, Kröner C, Klein C, Campo I, Luisetti M, Bonella F.

BMC Pulm Med. 2015 Aug 12;15:87. doi: 10.1186/s12890-015-0083-2.

49.

European protocols for the diagnosis and initial treatment of interstitial lung disease in children.

Bush A, Cunningham S, de Blic J, Barbato A, Clement A, Epaud R, Hengst M, Kiper N, Nicholson AG, Wetzke M, Snijders D, Schwerk N, Griese M; chILD-EU Collaboration.

Thorax. 2015 Nov;70(11):1078-84. doi: 10.1136/thoraxjnl-2015-207349. Epub 2015 Jul 1. Review.

50.

In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency.

Mahiny AJ, Dewerth A, Mays LE, Alkhaled M, Mothes B, Malaeksefat E, Loretz B, Rottenberger J, Brosch DM, Reautschnig P, Surapolchai P, Zeyer F, Schams A, Carevic M, Bakele M, Griese M, Schwab M, Nürnberg B, Beer-Hammer S, Handgretinger R, Hartl D, Lehr CM, Kormann MS.

Nat Biotechnol. 2015 Jun;33(6):584-6. doi: 10.1038/nbt.3241. Epub 2015 May 18. No abstract available.

PMID:
25985262

Supplemental Content

Loading ...
Support Center